BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10073901)

  • 1. Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results.
    Sawai H; Komori S; Ida A; Henmi T; Bessho T; Koyama K
    Prenat Diagn; 1999 Jan; 19(1):21-4. PubMed ID: 10073901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia.
    Chen CP; Chern SR; Shih JC; Wang W; Yeh LF; Chang TY; Tzen CY
    Prenat Diagn; 2001 Feb; 21(2):89-95. PubMed ID: 11241532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation.
    De Biasio P; Prefumo F; Baffico M; Baldi M; Priolo M; Lerone M; Tomà P; Venturini PL
    Prenat Diagn; 2000 Oct; 20(10):835-7. PubMed ID: 11038465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thanatophoric dysplasia type I associated with increased nuchal translucency in the first trimester: Early prenatal diagnosis using combined ultrasonography and molecular biology.
    Tonni G; Azzoni D; Ventura A; Ferrari B; Felice CD; Baldi M
    Fetal Pediatr Pathol; 2010; 29(5):314-22. PubMed ID: 20704477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of common mutations of the FGFR3 gene causing thanatophoric dysplasia type I: two case reports.
    Yang Y; Liu YN; Li DZ
    Fetal Pediatr Pathol; 2012 Jun; 31(3):128-33. PubMed ID: 22414243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-trimester molecular diagnosis of a heterozygous 742 --> T (R248C) mutation in the FGFR3 gene in a thanatophoric dysplasia variant following suspicious ultrasound findings.
    Chen CP; Chern SR; Wang W; Wang TY
    Ultrasound Obstet Gynecol; 2001 Mar; 17(3):272-3. PubMed ID: 11309183
    [No Abstract]   [Full Text] [Related]  

  • 7. A THANATOPHORIC DYSPLASIA TYPE I CASE WITH A FGFR3 P.R248C MUTATION AND SURVIVAL BEYOND THE NEONATAL PERIOD.
    Sahin S; Ograg H; Aslan EA; Akcan AB; Turkmen MK; Moosa S; Elcioglu NH
    Genet Couns; 2016; 27(4):513-517. PubMed ID: 30226972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex PCR in noninvasive prenatal diagnosis for FGFR3-related disorders.
    Terasawa S; Kato A; Nishizawa H; Kato T; Yoshizawa H; Noda Y; Miyazaki J; Ito M; Sekiya T; Fujii T; Kurahashi H
    Congenit Anom (Kyoto); 2019 Jan; 59(1):4-10. PubMed ID: 29542187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotyping of the C742T mutation of the FGFR3 gene causing type 1 thanatophoric dysplasia by high-resolution melting analysis.
    Liu YN; Li R; Li DZ
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):186-8. PubMed ID: 20569165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically confirmed thanatophoric dysplasia with fibroblast growth factor receptor 3 mutation.
    Jung M; Park SH
    Exp Mol Pathol; 2017 Apr; 102(2):290-295. PubMed ID: 28249712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased first-trimester nuchal translucency associated with thanatophoric dysplasia type 1.
    Zhen L; Pan M; Han J; Yang X; Liao C; Li DZ
    J Obstet Gynaecol; 2015; 35(7):685-7. PubMed ID: 25671245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second trimester molecular diagnosis of a stop codon FGFR3 mutation in a type I thanatophoric dysplasia fetus following abnormal ultrasound findings.
    Chen CP; Chern SR; Chang TY; Lin CJ; Wang W; Tzen CY
    Prenat Diagn; 2002 Aug; 22(8):736-7. PubMed ID: 12210587
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular, radiologic, and histopathologic correlations in thanatophoric dysplasia.
    Wilcox WR; Tavormina PL; Krakow D; Kitoh H; Lachman RS; Wasmuth JJ; Thompson LM; Rimoin DL
    Am J Med Genet; 1998 Jul; 78(3):274-81. PubMed ID: 9677066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An R248C mutation of FGFR3 leading to thanatophoric dysplasia type I.
    Tsai FJ; Tsai LP; Lin SP; Tsai CH; Peng CT; Wang TR; Lee CC; Wu JY
    Acta Paediatr Taiwan; 1999; 40(4):262-4. PubMed ID: 10910625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
    Tavormina PL; Shiang R; Thompson LM; Zhu YZ; Wilkin DJ; Lachman RS; Wilcox WR; Rimoin DL; Cohn DH; Wasmuth JJ
    Nat Genet; 1995 Mar; 9(3):321-8. PubMed ID: 7773297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G370C mutation in the FGFR3 gene in a Japanese patient with thanatophoric dysplasia.
    Katsumata N; Kuno T; Miyazaki S; Mikami S; Nagashima-Miyokawa A; Nimura A; Horikawa R; Tanaka T
    Endocr J; 1998 Apr; 45 Suppl():S171-4. PubMed ID: 9790257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR3 gene mutations in Chinese cases of thanatophoric dysplasia type 1.
    Yang Y; Li DZ
    Fetal Diagn Ther; 2009; 26(2):90-2. PubMed ID: 19752524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thanatoforic dysplasia--case report].
    Pietryga M; Iciek R; Brazert M; Wender-Ozegowska E; Brazert J
    Ginekol Pol; 2010 Jan; 81(1):55-60. PubMed ID: 20232701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved diagnosis of a common mutation (R248C) in the human growth factor receptor 3 (FGFR3) gene that causes type I Thanatophoric dysplasia.
    Simsek M; Al-Gazali L; Al-Mjeni R; Bayoumi R
    Clin Biochem; 2003 Mar; 36(2):151-3. PubMed ID: 12633765
    [No Abstract]   [Full Text] [Related]  

  • 20. Platyspondylic lethal skeletal dysplasia, San Diego type, is caused by FGFR3 mutations.
    Brodie SG; Kitoh H; Lachman RS; Nolasco LM; Mekikian PB; Wilcox WR
    Am J Med Genet; 1999 Jun; 84(5):476-80. PubMed ID: 10360402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.